UTMB develops a universal vaccine platform that’s cheaper and shelf stable
Researchers at The University of Texas Medical Branch at Galveston have developed a less expensive way to produce vaccines that cuts the cost of vaccine production and storage by 80 percent without decreasing safety or effectiveness. The findings are currently available in EBioMedicine.
Vaccines are the most effective way to prevent and eradicate infectious diseases. Currently, many vaccines have to be manufactured in cell culture or eggs, which is expensive and carries the risk of contaminations. In addition, most vaccines must be kept refrigerated during the transportation from manufacturers to health care clinics. In tropical and subtropical regions, such cold storage requirements could contribute to more than 80 percent of the vaccine cost.
“The ability to eliminate cell culture or eggs and cold storage will change the process of vaccine development,” said UTMB’s Pei-Yong Shi, professor in the department of biochemistry and molecular biology. “Importantly, this vaccine technology could potentially serve as a universal platform for development of live-attenuated vaccines for many viral pathogens.”
To achieve these goals, the UTMB team engineered a live-attenuated Zika vaccine in the DNA form. Once the DNA is delivered into our body, it launches the vaccine in our cells, leading to antibody production and other protective immunity. With this production method, there is no need to manufacture the vaccine in cell culture or eggs at factories. Because DNA molecules are shelf stable, the vaccine will not expire at warm temperatures and could be stockpiled at room temperature for years.
Using UTMB’s Zika vaccine as a model, the research group showed that the DNA platform worked very efficiently in mice. After a single low dose, the DNA vaccine protected mice from Zika virus infection, mother-to-fetus transmission during pregnancy and male reproductive tract infection and damage.
“This is the first study to demonstrate that, after a single low dose, a DNA vaccine could induce saturated protective immunity,” Shi said. “We will continue testing this promising Zika vaccine platform and then apply the platform to other viruses.”
The Latest on: Vaccine production
via Google News
The Latest on: Vaccine production
Progress reported in race to find vaccine for deadly hog disease spreading across China
on May 24, 2019 at 10:40 pm
"In the next step, the Chinese Academy of Agricultural Sciences will accelerate the progress of pilot and clinical trials, as well as vaccine production," said the report, based on an online posting ... […]
Utility of fentanyl vaccines: unique challenges posed by preventing opioid overdose and treating opioid use disorder
on May 24, 2019 at 11:35 am
In the current issue of Neuropsychopharmacology, Townsend et al.  reported a time course of efficacy for a fentanyl-tetanus toxoid conjugate vaccine designed to induce the production of ... […]
China says making progress on African swine fever vaccine
on May 24, 2019 at 12:14 am
“In the next step, the Chinese Academy of Agricultural Sciences will accelerate the progress of pilot and clinical trials, as well as vaccine production,” said the report. However, scientists who work ... […]
Swimming, s'mores and shots: Summer camps harden vaccine rules in US measles outbreak
on May 23, 2019 at 10:24 am
When commercial real estate investor Manny Khoshbin spent $2.2 million on the fastest production car in the world ... summer camps are tightening their policies on vaccines. Some camps are now ... […]
Global Vaccines Market Growth Opportunities - Forecast to 2024 by Production System, Antigens, Procurement System, and End Users
on May 23, 2019 at 5:09 am
Dublin, May 23, 2019 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Global Vaccines Market, Forecast to 2024" report has been added to ResearchAndMarkets.com's offering. The report provides an ... […]
Daiichi Sankyo comes up far short of promised avian flu vaccine production
on May 22, 2019 at 7:19 am
Daiichi Sankyo is apologizing to the Japanese people. The drugmaker is sorry for again missing a deadline to be able to quickly manufacture enough bird flu vaccine to help protect the country in case ... […]
What Older Adults Need To Know About Measles And Shingles Vaccines
on May 21, 2019 at 8:06 pm
manufacturing site to expand the production capacity of key components of Shingrix. An existing facility in France was approved by the Food and Drug Administration in January to produce Shingrix. GSK ... […]
Ebola Vaccine Market - Major Technology Giants in Buzz Again | Merck & Company, GlaxoSmithKline plc, Novavax
on May 20, 2019 at 5:07 am
Ebola Vaccine production, and CAGR (%). The global Ebola Vaccine market research report assists the user to propel their business by providing them detailed market insights. It guide them for planning ... […]
Aquaculture Vaccines Market Value to Hit $290 Million by 2025: Global Market Insights, Inc.
on May 20, 2019 at 1:08 am
Immersion vaccines allow immune cells located in the fish's gills and skin to become directly exposed to antigens. These immune cells may then witness antibody production, thus protecting the fish ... […]
via Bing News